Niraj Nandkishor Bari

Cell&Gene therapy/mAbs/Vaccine/Plasmids Downstream Processing

Role: Research Associate at Intas Pharmaceuticals
Location: Jalgaon, MH, IN
LinkedIn followers: 500 followers

ScienceView LinkedIn profile

About Niraj Nandkishor Bari

Experienced Research Associate with a proven track record in the Biopharmaceutical…

Experience

Research Associate
Intas Pharmaceuticals
Sep 2024 — Present · Ahmedabad, IN
Downstream Process Development for Viral VectorsPlasmid Purification & Tech TransferExecution for POC, preclinical, and clinical stages; provided micro-planning, documentation, and ensured GLP/GMP compliance.Drove process scale-up, technology transfer, and raw data documentation to meet regulatory and development milestones

Education

SSBT'S COLLEGE OF ENGINEERING & TECHNOLOGY, BAMBHORI.
Bachelor of Engineering - BE
2017 — 2021
GIET University Gunupur
Master of Technology - MTech
2022 — 2024

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@intaspharma.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Intas Pharmaceuticals

Pharmaceutical Manufacturing · 20K employees · Ahmedabad, Gujarat, India

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

intaspharma.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Niraj Nandkishor Bari

Experience

Research Associate

Education

SSBT'S COLLEGE OF ENGINEERING & TECHNOLOGY, BAMBHORI.

GIET University Gunupur

Find verified contacts for anyone on LinkedIn